Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Screening Biomarker, Diagnosis Biomarker); Application (Diagnostics, Drug Discovery, Personalized Medicine, Others)

Report Code: TIPRE00013511 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Prostate-specific antigen (PSA) is a protein formed by healthy, as well as malignant cells of the prostate gland. The PSA test measures the level of PSA in a man's blood. For this test, a blood sample is sent to a laboratory for analysis. Detecting prostate cancer initially may not reduce the chance of dying from prostate cancer.

MARKET DYNAMICS

The prostate specific antigen (PSA) blood based biomarker market is driving due to the rising prevalence of cancer, growing healthcare expenditure, and favorable reimbursement policies. However, the high cost of treatment is expected to hamper the global prostate specific antigen (PSA) blood based biomarker market. Moreover, the rising R&D expenditure in biomarkers is anticipated to drive demand for the growth of the market for prostate specific antigen (PSA) blood based biomarker.

MARKET SCOPE

The "Prostate Specific Antigen (PSA) Blood Based Biomarker Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of prostate specific antigen (PSA) blood based biomarker market with detailed market segmentation by type and application. The prostate specific antigen (PSA) blood based biomarker market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in prostate specific antigen (PSA) blood based biomarker market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The prostate specific antigen (PSA) blood based biomarker market is segmented on the basis of type and application. Based on type, the market is segmented as screening biomarker and diagnosis biomarker. On the basis of application, the market is categorized as diagnostics, drug discovery, personalized medicine, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the prostate specific antigen (PSA) blood based biomarker market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Prostate specific antigen (PSA) blood based biomarker market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting prostate specific antigen (PSA) blood based biomarker market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the prostate specific antigen (PSA) blood based biomarker market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the prostate specific antigen (PSA) blood based biomarker market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Prostate specific antigen (PSA) blood based biomarker market is anticipated to have lucrative growth opportunities in the future with the rising demand for Prostate specific antigen (PSA) blood based biomarker in the global market. Below mentioned is the list of few companies engaged in the Prostate specific antigen (PSA) blood based biomarker market.

The report also includes the profiles of key players in prostate specific antigen (PSA) blood based biomarker market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Proteomedix
  •   Cleveland Diagnostics, Inc.
  •   Randox Laboratories Ltd.
  •   F. Hoffmann-La Roche Ltd
  •   GENFIT
  •   NUTECH CANCER BIOMARKERS INDIA PRIVATE LIMITED
  •   OGT (Sysmex Group)
  •   MINOMIC
  •   Creative Diagnostics
  •   Decipher Biosciences, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market - By Type
1.3.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Market - By Application
1.3.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PROSTATE SPECIFIC ANTIGEN (PSA) BLOOD BASED BIOMARKER MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PROSTATE SPECIFIC ANTIGEN (PSA) BLOOD BASED BIOMARKER MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PROSTATE SPECIFIC ANTIGEN (PSA) BLOOD BASED BIOMARKER MARKET - GLOBAL MARKET ANALYSIS
6.1. PROSTATE SPECIFIC ANTIGEN (PSA) BLOOD BASED BIOMARKER - GLOBAL MARKET OVERVIEW
6.2. PROSTATE SPECIFIC ANTIGEN (PSA) BLOOD BASED BIOMARKER - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PROSTATE SPECIFIC ANTIGEN (PSA) BLOOD BASED BIOMARKER MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SCREENING BIOMARKER
7.3.1. Overview
7.3.2. Screening Biomarker Market Forecast and Analysis
7.4. DIAGNOSIS BIOMARKER
7.4.1. Overview
7.4.2. Diagnosis Biomarker Market Forecast and Analysis
8. PROSTATE SPECIFIC ANTIGEN (PSA) BLOOD BASED BIOMARKER MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DIAGNOSTICS
8.3.1. Overview
8.3.2. Diagnostics Market Forecast and Analysis
8.4. DRUG DISCOVERY
8.4.1. Overview
8.4.2. Drug Discovery Market Forecast and Analysis
8.5. PERSONALIZED MEDICINE
8.5.1. Overview
8.5.2. Personalized Medicine Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. PROSTATE SPECIFIC ANTIGEN (PSA) BLOOD BASED BIOMARKER MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Overview
9.1.2 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis
9.1.3 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis - By Type
9.1.4 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis - By Application
9.1.5 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis - By Countries
9.1.5.1 United States Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.1.5.1.1 United States Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.1.5.1.2 United States Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
9.1.5.2 Canada Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.1.5.2.1 Canada Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.1.5.2.2 Canada Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
9.1.5.3 Mexico Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.1.5.3.1 Mexico Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.1.5.3.2 Mexico Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
9.2. EUROPE
9.2.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Overview
9.2.2 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis
9.2.3 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis - By Type
9.2.4 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis - By Application
9.2.5 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.2.5.1.1 Germany Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.2.5.1.2 Germany Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
9.2.5.2 France Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.2.5.2.1 France Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.2.5.2.2 France Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
9.2.5.3 Italy Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.2.5.3.1 Italy Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.2.5.3.2 Italy Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
9.2.5.4 Spain Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.2.5.4.1 Spain Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.2.5.4.2 Spain Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
9.2.5.5 United Kingdom Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.2.5.5.1 United Kingdom Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.2.5.5.2 United Kingdom Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Overview
9.3.2 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis
9.3.3 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.3.5.1.1 Australia Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.3.5.1.2 Australia Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
9.3.5.2 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.3.5.2.1 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.3.5.2.2 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
9.3.5.3 India Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.3.5.3.1 India Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.3.5.3.2 India Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
9.3.5.4 Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.3.5.4.1 Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.3.5.4.2 Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
9.3.5.5 South Korea Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.3.5.5.1 South Korea Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.3.5.5.2 South Korea Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Overview
9.4.2 Middle East and Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis
9.4.3 Middle East and Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.4.5.1.1 South Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.4.5.1.2 South Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
9.4.5.2 Saudi Arabia Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.4.5.2.1 Saudi Arabia Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.4.5.2.2 Saudi Arabia Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
9.4.5.3 U.A.E Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.4.5.3.1 U.A.E Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.4.5.3.2 U.A.E Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Overview
9.5.2 South and Central America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis
9.5.3 South and Central America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis - By Type
9.5.4 South and Central America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis - By Application
9.5.5 South and Central America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.5.5.1.1 Brazil Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.5.5.1.2 Brazil Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
9.5.5.2 Argentina Prostate Specific Antigen (PSA) Blood Based Biomarker Market
9.5.5.2.1 Argentina Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Type
9.5.5.2.2 Argentina Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PROSTATE SPECIFIC ANTIGEN (PSA) BLOOD BASED BIOMARKER MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PROSTATE SPECIFIC ANTIGEN (PSA) BLOOD BASED BIOMARKER MARKET, KEY COMPANY PROFILES
12.1. PROTEOMEDIX
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CLEVELAND DIAGNOSTICS, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. RANDOX LABORATORIES LTD.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. F. HOFFMANN-LA ROCHE LTD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GENFIT
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NUTECH CANCER BIOMARKERS INDIA PRIVATE LIMITED
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. OGT (SYSMEX GROUP)
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MINOMIC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. CREATIVE DIAGNOSTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. DECIPHER BIOSCIENCES, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Proteomedix
2. Cleveland Diagnostics, Inc.
3. Randox Laboratories Ltd.
4. F. Hoffmann-La Roche Ltd
5. GENFIT
6. NUTECH CANCER BIOMARKERS INDIA PRIVATE LIMITED
7. OGT (Sysmex Group)
8. MINOMIC
9. Creative Diagnostics
10. Decipher Biosciences, Inc.
TIPRE00013511
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking